Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02289118 · ClinicalTrials.gov registry record
Tau Imaging in Young Onset Dementia
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 16
- Enrollment target
NCT02289118: Completed study, sponsored by University of Pennsylvania.
NCT02289118 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02289118 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The central goal of this study is to determine and compare the similarities and differences in regional brain uptake of \[18F\]T807 in patients with typical Alzheimer's Disease (AD), Posterior Cortical Atrophy (PCA), and Logopenic Variant of Primary Progressive Aphasia (lvPPA). The investigators will correlate patterns of \[18F\]T807 binding with magnetic resonance imaging (MRI)-based regional volumetric and cortical thickness measures. If cerebral spinal fluid (CSF) samples are not available, patients may be asked to get an optional lumbar puncture (LP) for additional comparisons. The investigators will recruit 20 participants, 45-70 years old, with clinical evidence of young onset focal dementia.
Interventions
- DRUG [18F]-T807 imaging tracer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02289118
The ClinicalTrials.gov registry entry for NCT02289118 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]-T807 imaging tracer is the first listed.
NCT02289118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02289118 about?
NCT02289118 is a clinical study titled "Tau Imaging in Young Onset Dementia". The central goal of this study is to determine and compare the similarities and differences in regional brain uptake of \[18F\]T807 in patients with typical Alzheimer's Disease (AD), Posterior Cortical Atrophy (PCA), and Logopenic Variant of Primary Progressive Aphasia (lvPPA). The investigators wil...
What is the current status of trial NCT02289118?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2014-11. Estimated completion is 2019-01-31.
What interventions are being tested in trial NCT02289118?
The interventions under investigation include: [18F]-T807 imaging tracer (DRUG).
Who is sponsoring clinical trial NCT02289118?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.